Provided herein are stable enalapril powder compositions for oral liquid formulation. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
申请公布号
US8568747(B1)
申请公布日期
2013.10.29
申请号
US201213670355
申请日期
2012.11.06
申请人
UNIVERSITY OF KANSAS;SILVERGATE PHARMACEUTICALS;SILVERGATE PHARMACEUTICALS, INC.
发明人
RAJEWSKI LIAN G.;RAJEWSKI ROGER A.;HASLAM JOHN L.;HEPPERT KATHLEEN;BECKLOFF MICHAEL C.;SEAGRAVE FRANK;MAURO ROBERT;COLABUONO PETER
